Table 1. Correlation between HOXA-AS2 expression and clinicopathological characteristics of gastric cancer patients.
| Characteristics | N(%) | HOXA-AS2 | p Chi-squared test P-value | |
|---|---|---|---|---|
| High | Low | |||
| Gender | 0.573 | |||
| Male | 37(67.3%) | 20 | 17 | |
| Female | 18(32.7%) | 8 | 10 | |
| Age | 0.423 | |||
| ≤65 | 28(50.9%) | 16 | 12 | |
| > 65 | 27(49.1%) | 12 | 15 | |
| Histological subtype | 0.285 | |||
| Squamous cell carcinoma | 28(50.9%) | 12 | 16 | |
| Adenocarcinoma | 27(49.1%) | 16 | 11 | |
| Stage | 0.011* | |||
| III | 25(45.5%) | 8 | 17 | |
| III | 30(54.5%) | 20 | 10 | |
| Lymph node metastasis | 0.032* | |||
| Negative | 17(30.9%) | 5 | 12 | |
| Positive | 38(69.1%) | 23 | 15 | |
| Tumor size | 0.007* | |||
| 55 cm | 15(27.3%) | 3 | 12 | |
| > 5 cm | 40(72.7%) | 25 | 15 | |
*
P < 0.05 was considered significant (Chi-square test between 2 groups).